Navigation Links
Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
Date:11/7/2011

htsSix Oral Presentations and two Poster Presentations for Btk Inhibitor, PCI-32765, have been accepted at the American Society of Hematology (ASH) Annual Meeting in San Diego, CA (Dec 10-13th, 2011).  The clinical presentations during ASH will provide significant updates regarding the efficacy and safety of PCI-32765 in chronic lymphocytic leukemia, mantle cell lymphoma, and activated B-cell subtype diffuse large B-cell lymphoma. The company will hold a conference call following the ASH presentations on December 14th, 2011. The abstracts will be published today on the ASH website at www.hematology.org at approximately 10:00 a.m. ET.

Clinical Presentations

  • Mantle Cell Lymphoma Oral Presentation
  • Title: The Bruton's Tyrosine Kinase Inhibitor PCI-32765 Is Highly Active As Single-Agent Therapy in Previously-Treated Mantle Cell Lymphoma (MCL): Preliminary Results of a Phase II Trial (#442)
  • Session: Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models: Mantle Cell and T Cell Lymphoma - Targeted Antibody and Small Molecule Approaches
  • Date/Time: Monday, December 12, 2011; 11:15 a.m. Pacific Time
  • Location: Ballroom 20A
  • Presenter: Michael Wang, MD, University of Texas MD Anderson Cancer Center, Houston, TX

  • Chronic Lymphocytic Leukemia Oral Presentation
  • Title: The Bruton's Tyrosine Kinase (BTK) Inhibitor PCI-32765 Induces Durable Responses in Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Follow-up of a Phase Ib/II Study (#983)
  • Session: CLL - Therapy, excluding Transplantation: Relapse treatment, novel agents and treatment related complications
  • Date/Time: Tuesday, December 13, 2011; 8:30 a.m. Pacific Time 
  • Location: Ballroom 20A
  • Presenter: Susan O'Brien, MD, University of Texas MD Anderson Cancer Center,
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
    2. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
    3. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
    4. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
    5. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
    6. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
    7. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
    8. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
    9. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
    10. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
    11. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... 2014 PositiveID Corp. (OTCQB: PSID), based in ... an emerging player in the bio-threat detection market, ... and rapid medical testing. The Company,s proprietary airborne ... Networked Detector), was developed under contract with the ... Technology directorate, and $30 million of contract funding. ...
    (Date:7/23/2014)... Pa. , July 23, 2014 /PRNewswire/ ... today announced successful results from its randomized, ... in women with biopsy-proven cervical intraepithelial neoplasia ... types 16 or 18. Treatment with VGX-3100, ... of CIN2/3 to CIN1 or no disease, ...
    (Date:7/23/2014)... -- Nearly 8,000 attendees will converge in Washington ... Conference (RBC), taking place July 23-26 at the Gaylord ... pharmacists to "Lead Change" in the pharmacy profession, in ... their future. "RBC is the perfect opportunity ... and learn new ways they can lead change in ...
    Breaking Medicine Technology:PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6
    ...  Responding to a need for better post-market surveillance of orthopedic ... Consortium of Orthopaedic Registries in October 2010. As ... Journal of Bone and Joint Surgery , ... for improving the safety of orthopedic devices using outcomes registries ...
    ... Dec. 21, 2011 Senate Democratic Leader John L. ... and CEO of Walgreens Inc., expressing his dismay about ... drug coverage more affordable for many of the low-income ... Walgreens has administered the program through Express Scripts, ...
    Cached Medicine Technology:Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 2Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 3Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 4
    (Date:7/23/2014)... 2014 The next episode of “Extreme ... Wis. who was physically fit through childhood and adolescence. ... made the heart-wrenching decision to give her son up ... past 18 years, and she punished herself by overeating, ... a unique, non-competitive approach to weight loss transformations, “Extreme ...
    (Date:7/23/2014)... 23, 2014 Home Care Assistance ... for seniors, is proud to announce the next installment ... in a wide range of health and wellness-related fields. ... and award-winning author Nancy Kriseman, and will cover the ... prevent burnout by becoming more self-aware. In particular, Nancy ...
    (Date:7/23/2014)... or itchy skin lesions could be a warning sign ... multiple lesions that are suspicious looking, and those that ... non-melanoma skin cancers," study author Dr. Gil Yosipovitch, chairman ... in a Temple University Health System news release. ... who were confirmed to have skin cancer lesions between ...
    (Date:7/23/2014)... body of research suggesting a safe and effective ... breast cancer, with fewer detrimental side effects and ... The study will be published in final format ... and Endocrinology . , Breast cancer is the ... United States. Approximately 70% of breast cancers are ...
    (Date:7/23/2014)... The National Institute of Biomedical Imaging and Bioengineering ... Symposium on July 30, 2014 on the NIH campus. ... investigators covering a wide breadth of NIBIB-funded research. ... Cohen, Harvard, Engineering Microbial Rhodopsins as Optical Voltage Sensor, ... Fluorescently Labeled Probes for Nerve Imaging ...
    Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
    ... Dec. 15 Today, the U.S. Food,and Drug Administration ... along with diet to help lower triglycerides,and LDL cholesterol, ... TRILIPIX is the first and only fibrate to ... In certain patients, treatment guidelines,recommend the combination of a ...
    ... Matthew L. Myers President, Campaign for Tobacco-Free Kids , ... U.S. Supreme Court today handed down a major victory for ... state consumer protection laws to sue Philip Morris and other ... Today,s ruling poses a significant legal threat to the ...
    ... Controlling Costs, Improving Quality as Health Care Reform Debate Centers on ... Dec. 15 House Ways and Means Health Subcommittee Chairman ... counsel to Sen. Max Baucus, will join health care expert and ... Future co-director Roger Hickey on a conference call with ...
    ... Dec. 15 Following is a statement from Michael ... in regards to its financial exposure with Madoff Securities: ... Health System,s financial exposure with Madoff Securities is limited to ... who stipulated that the funds be invested with Madoff. The ...
    ... Dec. 15 The American Red Cross sheltered hundreds of people ... Northeast. Working with local partners, Red Cross chapters opened shelters in ... , "Unfortunately, ice storms are par for ... is always ready to give people a safe and warm place ...
    ... Lab study showed it had effect on 60% Of malignant ... produced by the oncogene MYC can stop the spread of ... that has the potential to help cause cancer. , In ... overly active. This causes the ovarian cells to produce excessive ...
    Cached Medicine News:Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 2Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 3Health News:North Shore-LIJ Health System Exposure With Madoff Securities Limited to $5.7M 2Health News:Red Cross Shelters Hundreds as Severe Weather Hits Northeast 2
    The KMedic Jet Wire Twister is designed to provide fast, smooth and even twisting of soft wire, saving time in the O.R. Now available for the first time in stainless steel. Suitable for the entire ra...
    Lead filled and faced bone mallet used to exert force on osteotomes, chisels, and gouges....
    Slightly curved Periosteal elevator....
    Straight chisel for scoring, cutting, scraping, cleaning and sculpting bone....
    Medicine Products: